IMMATICS NV- WARRANTS
IMMATICS NV- WARRANTS
Aktie · NL0015285958 · IMTXW (XNAS)
Übersicht Finanzkennzahlen
0,01 USD
-6,00 % -0,0009 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
11.06.2025 15:27

Aktuelle Kurse von IMMATICS NV- WARRANTS

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
IMTXW
USD
11.06.2025 15:27
0,01 USD
0,02 USD
-6,00 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % -48,73 % 1,44 % -29,85 % -96,03 % -99,63 % -99,74 %

Firmenprofil zu IMMATICS NV- WARRANTS Aktie

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401, which is in Phase 1b clinical trial; and IMA402 and IMA403, which are in preclinical stages. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.

Unternehmensdaten

Name IMMATICS NV- WARRANTS
Firma immatics biotechnologies GmbH
Symbol IMTXW
Website https://www.immatics.com
Heimatbörse XNAS NASDAQ
ISIN NL0015285958
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Harpreet Singh Ph.D.
Marktkapitalisierung 387 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,6 T
Adresse Paul-Ehrlich-Strasse 15, 72076 Tübingen
IPO Datum 2020-07-02

Ticker Symbole

Name Symbol
NASDAQ IMTXW

Weitere Aktien

Investoren die IMMATICS NV- WARRANTS die halten, haben auch folgende Aktien im Depot:
AMC ENTERTAINMENT S A
AMC ENTERTAINMENT S A Aktie
BALLARD PWR SYS
BALLARD PWR SYS Aktie
BLUESCAPE OPPORTUNITIES ACQUISITION CORP CLASS A
BLUESCAPE OPPORTUNITIES ACQUISITION CORP CLASS A Aktie
Cohn Robbins Holdings Corp.
Cohn Robbins Holdings Corp. Aktie
DZ BANK      IS.2725
DZ BANK IS.2725 Anleihe
FUELCELL ENERGY
FUELCELL ENERGY Aktie
INFOR.MAISON INT. EO -,10
INFOR.MAISON INT. EO -,10 Aktie
INSTRUMENT US3498851035
INSTRUMENT US3498851035 Unbekannt
INSTRUMENT US92244F1176
INSTRUMENT US92244F1176 Unbekannt
NANO DIMENSION LTDICAN DEPOSITARY SHARES
NANO DIMENSION LTDICAN DEPOSITARY SHARES Hinterlegungsschein
NIKOLA CORP
NIKOLA CORP Aktie
ORIGIN MATER. A  DL-,0001
ORIGIN MATER. A DL-,0001 Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025